Research

2009-2012 Research Investments

AllerGen Funded Cross-programmatic Research Teams 2009-2012

Dalhousie University

§ The Canadian Group on Food Allergy Research (CanGoFAR)

Principal Investigator, J. Marshall, Dalhousie University $750,000

Hospital for Sick Children, University of Toronto

§ Respiratory syncytial virus in the development of infant wheezing

disorders: a bench to bedside approach to gene-virus interactions

Principal Investigator PJ. Subbarao, The Hospital for Sick Children,

University of Toronto $176,800

McGill University Health Centre, McGill University

§ Surveying Prevalence of food Allergy in All Canadian

Environments (SPAACE) Study

Principal Investigator A. Clarke, McGill University Health Centre $531,450

McMaster University

§ Hemopoietic stem cell biomarkers in the diagnosis and prediction

of allergic inflammation and disease

Principal Investigator D. Denburg, McMaster University $654,220

§ Clinical Investigator Collaborative (CIC

Principal Investigator P. O’Byrne, McMaster University $1,330,000

§ The distribution and function of FceR1 on nerves

Principal Investigator J. Bienenstock, McMaster University $182,951

§ Can e-health tools improve health outcomes in asthma?

Principal Investigator A. Levinson, McMaster University: $100,000

Queen’s University

§ Work-Related Asthma and Allergy: Prevention and Early Detection

(WRAAPPED) research program

Principal Investigator D. Lougheed, Queen’s University $600,000

St. Joseph’s Healthcare

§ Developmental plasticity and fetal programming of asthma in mice

Principal Investigator, P. Forsythe, St. Joseph's Healthcare $192,396

University of Alberta

§ Neuroimmune interactions: a partnership in drug development

and translational research

Principal Investigator D. Befus, University of Alberta $249,143

§ Evidence, ethics and health policy research

Principal Investigator T. Caulfield, University of Alberta $300,000

§ Engaging Aboriginal families affected by allergies and asthma in

support-education program development

Principal Investigator, M. Stewart, University of Alberta $400,000

§ Non-invasive assessment of atopic diseases: Metabolomic

profiling of urine using Nuclear Magnetic Resonance

Principal Investigator D. Adamko, University of Alberta $302,130

University of British Columbia

Genome wide association study of allergy and asthma in the Canadian Asthma Primary Prevention Study (CAPPS) and the Study of Allergy Genes and Environment (SAGE)

Principal Investigator P. Paré, University of British Columbia $326,696

Traffic-related air pollution as a risk factor for the development of childhood asthma

Principal Investigator M. Brauer, University of British Columbia $516,563

§ Functional genetics in allergy

Principal Investigator A. Sandford, University of British Columbia $447,750

§ After allergen challenge, why do some individuals develop an

isolated early response while other individuals develop both early

and late phase responses? Addressing this question by studying

unique cohorts of asthmatic and allergic rhinitis subjects, using

functional genomics, proteomics and genetics.

Principal Investigator S. Tebbutt, University of British Columbia $216,288

§ Vaccines for asthma & allergies - a bacterial immune-prophylactic

and therapeutic approach

Principal Investigator T. Kollmann, University of British Columbia $265,500

Environmental impact, inflammation and the role of IL-13 receptor a2

Principal Investigator, D. Dorschied, University of British Columbia $100,000

§ Platform for Outcomes Research and Translation in Asthma
and Allergy (PORTAL)

Principal Investigator L. Lynd, University of British Columbia $300,000

In addition, the CHILD Study has received $3 million to fund four recruitment sites - Vancouver, Winnipeg, Alberta and Toronto - and one administrative centre based in Hamilton